Predicting Adverse Cardiovascular Events in Emergencies Due to Drug Overdose
预测因药物过量导致的紧急情况下的不良心血管事件
基本信息
- 批准号:7809615
- 负责人:
- 金额:$ 17.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-05-01 至 2014-04-30
- 项目状态:已结题
- 来源:
- 关键词:Accident and Emergency departmentAcuteAcute Physiology and Chronic Health EvaluationAddressAdmission activityAdverse eventAffectAge-YearsAnnual ReportsAntidepressive AgentsAntipsychotic AgentsBiological MarkersBlindedBuprenorphineCardiacCardiologyCardiovascular systemCessation of lifeCharacteristicsChest PainClinicalClinical DataComaComplicationConsensusDataData ElementDatabasesDemographic AgingDiagnostic testsDrug PrescriptionsDrug abuseEconomicsElectrocardiogramElectrocardiographic FindingEmergency CareEmergency SituationEnrollmentEpidemiologyEthnic OriginEvaluationEventFutureGenderGuidelinesHeart ArrestHospitalsIncidenceInfarctionInformation SystemsInjuryInternationalIschemiaLiteratureMentored Patient-Oriented Research Career Development AwardMentorsMentorshipMethamphetamineMorbidity - disease rateMyocardialNew York CityOpioidOverdosePatientsPharmaceutical PreparationsPhysical ExaminationPoisonPoison Control CentersPoisoningPrincipal InvestigatorProspective StudiesPublic Health SchoolsRaceRecording of previous eventsReportingResearchResearch PersonnelRiskRisk FactorsScientistSeizuresSensitivity and SpecificitySerumSeveritiesShockStratificationSubgroupSympathomimeticsSymptomsSystemTeaching HospitalsTestingTherapeuticTimeToxicologyTraining ActivityTraining ProgramsUnited StatesVentricularVisitaddictionadjudicateadjudicationbaseclinical decision-makingcohortdemographicsimprovedinnovationmedical schoolsmeetingsmortalitynovelprescription drug abusepreventprognostic indicatorprospectivepublic health relevancesocioeconomicsstatisticssuicidalsymposiumtool
项目摘要
DESCRIPTION (provided by applicant): The purpose of this mentored patient-oriented research career development award (K23) is to assist Alex Manini, MD to become an independent research scientist in drug overdose emergencies. Guided by Dr. David Vlahov (mentor), he will collaborate with accomplished investigators to study adverse cardiovascular events (ACVE) in drug overdose, building upon exciting preliminary data. Training activities include courses in statistics and epidemiology at the Columbia Mailman School of Public Health; the Addiction Training program at Mount Sinai School of Medicine; focused mentorship in drug overdose, epidemiology, and cardiology; and presentation of interim results at regional, national, and international conferences. Proposed is a prognostic indicator study of emergency department patients with drug overdose to evaluate occurrence of in-hospital ACVE. Based on preliminary data, the hypothesis is that clinical risk factors (e.g., demographics, exposure intent, electrocardiogram) will independently predict in-hospital ACVE. The specific aims are: (1) to determine the incidence of ACVE in patients with drug overdose; (2) to identify prognostic indicators for in-hospital ACVE in patients with drug overdose; and (3) to derive a simple risk stratification scoring system based on the above prognostic indicators for ACVE and to test the diagnostic characteristics of the risk score to aid clinical decision-making for patients with acute drug overdose. To meet these aims, emergency department patients with drug overdose at two urban teaching hospitals will be prospectively enrolled and followed longitudinally for occurrence of in-hospital ACVE. Overdose severity will be assessed with Poison Severity Scores, Acute Physiology and Chronic Health Evaluation, and adjudicated ACVE endpoints. Interpretation of the admission electrocardiogram will be performed by a blinded cardiologist, and serum will be evaluated for toxicology screens and cardiac biomarkers. Prognostic indicators for ACVE will be derived and incorporated into a simple risk score with a cutpoint chosen to achieve optimal diagnostic test characteristics. Implementation of this risk stratification tool has the potential to prevent AGVE complications for an estimated 1.5 million drug-related emergency department visits in the U.S. annually.
PUBLIC HEALTH RELEVANCE: Drug overdose and prescription drug abuse affect diverse demographics, races/ethnicities, and economic classes. Poisoning is the second leading cause of injury-related fatality in the U.S., and the leading cause of cardiac arrest in victims under 40 years of age. There are 2.4 million reported poison exposures and approximately 1.5 million drug-related emergencies in the U.S. annually.
描述(由申请人提供):这项受过指导的以患者为导向的研究职业发展奖(K23)的目的是协助医学博士Alex Manini,成为药物过量紧急情况的独立研究科学家。在戴维·弗拉霍夫(David Vlahov)博士(导师)的指导下,他将与成熟的研究人员合作研究药物过量的不良心血管事件(ACVE),基于令人兴奋的初步数据。培训活动包括哥伦比亚邮政公共卫生学院的统计和流行病学课程;西奈山医学院的成瘾培训计划;专注于药物过量,流行病学和心脏病学的指导;以及在地区,国家和国际会议上的临时结果。提议的是对药物过量患者的预后指标研究,以评估院内囊泡的发生。基于初步数据,假设是临床危险因素(例如人口统计学,暴露意图,心电图)将独立预测院内障碍。具体目的是:(1)确定药物过量患者的ACVE的发生率; (2)确定药物过量患者院内囊泡的预后指标; (3)基于上述ACVE的预后指标得出一个简单的风险分层评分系统,并测试风险评分的诊断特征,以帮助急性药物过量患者的临床决策。为了满足这些目标,将有前瞻性地入学,在两家城市教学医院服用药物过量的急诊科患者,并纵向遵循发生院内障碍。过量的严重程度将通过毒药的严重程度评分,急性生理和慢性健康评估以及裁定的ACVE终点评估。盲人心脏病专家将对入院心电图进行解释,并将评估血清毒理学筛查和心脏生物标志物。 ACVE的预后指标将被得出并纳入简单的风险评分中,并选择一个可获得最佳诊断测试特征的切割点。该风险分层工具的实施有可能预防估计每年在美国进行150万次与药物有关的急诊科访问的agve并发症。
公共卫生相关性:药物过量和处方药滥用会影响各种人口统计学,种族/种族和经济阶层。中毒是美国与受伤有关的第二大原因,也是40岁以下受害者心脏骤停的主要原因。每年在美国,有240万次毒药暴露和约150万与药物有关的紧急情况。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alex Francis Manini其他文献
Alex Francis Manini的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alex Francis Manini', 18)}}的其他基金
Predicting medical consequences of novel fentanyl analog overdose using the Toxicology Investigators Consortium (TOXIC)
使用毒理学研究联盟 (TOXIC) 预测新型芬太尼类似物过量的医疗后果
- 批准号:
10160611 - 财政年份:2020
- 资助金额:
$ 17.63万 - 项目类别:
Predicting medical consequences of novel fentanyl analog overdose using the Toxicology Investigators Consortium (TOXIC)
使用毒理学研究联盟 (TOXIC) 预测新型芬太尼类似物过量的医疗后果
- 批准号:
10343784 - 财政年份:2020
- 资助金额:
$ 17.63万 - 项目类别:
Predicting medical consequences of novel fentanyl analog overdose using the Toxicology Investigators Consortium (TOXIC)
使用毒理学研究联盟 (TOXIC) 预测新型芬太尼类似物过量的医疗后果
- 批准号:
10548822 - 财政年份:2020
- 资助金额:
$ 17.63万 - 项目类别:
Predicting medical consequences of novel fentanyl analog overdose using the Toxicology Investigators Consortium (TOXIC)
使用毒理学研究联盟 (TOXIC) 预测新型芬太尼类似物过量服用的医疗后果
- 批准号:
10546762 - 财政年份:2020
- 资助金额:
$ 17.63万 - 项目类别:
Predicting medical consequences of novel fentanyl analog overdose using the Toxicology Investigators Consortium (TOXIC)
使用毒理学研究联盟 (TOXIC) 预测新型芬太尼类似物过量服用的医疗后果
- 批准号:
9973939 - 财政年份:2020
- 资助金额:
$ 17.63万 - 项目类别:
Prevention of the cardiovascular medical consequences of drug overdose
预防药物过量造成的心血管医学后果
- 批准号:
9321939 - 财政年份:2014
- 资助金额:
$ 17.63万 - 项目类别:
Prevention of the cardiovascular medical consequences of drug overdose
预防药物过量造成的心血管医学后果
- 批准号:
9034300 - 财政年份:2014
- 资助金额:
$ 17.63万 - 项目类别:
Prevention of the cardiovascular medical consequences of drug overdose
预防药物过量造成的心血管医学后果
- 批准号:
8925040 - 财政年份:2014
- 资助金额:
$ 17.63万 - 项目类别:
Predicting Adverse Cardiovascular Events in Emergencies Due to Drug Overdose
预测因药物过量导致的紧急情况下的不良心血管事件
- 批准号:
8260540 - 财政年份:2009
- 资助金额:
$ 17.63万 - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
- 批准号:82300173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
- 批准号:82360957
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:地区科学基金项目
相似海外基金
A prospective study of posttraumatic stress symptom development and cannabis use among trauma exposed injured emerging adults following Emergency Department discharge
急诊科出院后遭受创伤的受伤新兴成年人的创伤后应激症状发展和大麻使用的前瞻性研究
- 批准号:
10598073 - 财政年份:2022
- 资助金额:
$ 17.63万 - 项目类别:
A prospective study of posttraumatic stress symptom development and cannabis use among trauma exposed injured emerging adults following Emergency Department discharge
急诊科出院后遭受创伤的受伤新兴成年人的创伤后应激症状发展和大麻使用的前瞻性研究
- 批准号:
10331947 - 财政年份:2022
- 资助金额:
$ 17.63万 - 项目类别:
Cannabis use following trauma exposure: An observational study of the impact of acute stress and fear response on cannabis outcomes
创伤暴露后使用大麻:急性压力和恐惧反应对大麻结果影响的观察性研究
- 批准号:
10444156 - 财政年份:2022
- 资助金额:
$ 17.63万 - 项目类别:
Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE
镰状细胞病和心血管风险 - 红细胞交换 SCD-CARRE
- 批准号:
10653703 - 财政年份:2022
- 资助金额:
$ 17.63万 - 项目类别:
Cannabis use following trauma exposure: An observational study of the impact of acute stress and fear response on cannabis outcomes
创伤暴露后使用大麻:急性压力和恐惧反应对大麻结果影响的观察性研究
- 批准号:
10682437 - 财政年份:2022
- 资助金额:
$ 17.63万 - 项目类别: